Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Hadaschik

Showing results (181-190 of 269) with videos related to

Pageof 27
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI TrialGregor Habl, Matthias Uhl, Sonja Katayama, et al.
Scientific Reports|November 17, 2016
ELMO1 protects renal structure and ultrafiltration in kidney development and under diabetic conditionsKrishna Rakesh Sharma, Karl Heckler, Sandra J Stoll, et al.
Cancer Medicine|October 7, 2022
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancerCsilla Olah, Henning Reis, Michèle J Hoffmann, et al.
Asian Journal of Andrology|March 1, 2016
Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measuresKaran Wadhwa, Lina Carmona-Echeveria, Timur Kuru, et al.
European Urology Open Science|April 21, 2025
Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE StudyRouvier Al-Monajjed, Lars Schimmöller, Jan Philipp Radtke, et al.
Prostate Cancer and Prostatic Diseases|December 12, 2022
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysisTamás Fazekas, Ádám D Széles, Brigitta Teutsch, et al.
Scientific Reports|October 13, 2023
Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective studyMelinda Váradi, Orsolya Horváth, Orsolya Módos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
<sup>68</sup>Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate CancerMaria Vinsensia, Peter L Chyoke, Boris Hadaschik, et al.
BJU International|May 27, 2018
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancerTibor Szarvas, Sabina Sevcenco, Orsolya Módos, et al.
The Journal of Pathology. Clinical Research|January 16, 2025
Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapyCsilla Olah, Oleksandr Shmorhun, Gilbert Georg Klamminger, et al.
Pageof 27

Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI TrialGregor Habl, Matthias Uhl, Sonja Katayama, et al.
Scientific Reports|November 17, 2016
ELMO1 protects renal structure and ultrafiltration in kidney development and under diabetic conditionsKrishna Rakesh Sharma, Karl Heckler, Sandra J Stoll, et al.
Cancer Medicine|October 7, 2022
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancerCsilla Olah, Henning Reis, Michèle J Hoffmann, et al.
Asian Journal of Andrology|March 1, 2016
Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measuresKaran Wadhwa, Lina Carmona-Echeveria, Timur Kuru, et al.
European Urology Open Science|April 21, 2025
Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE StudyRouvier Al-Monajjed, Lars Schimmöller, Jan Philipp Radtke, et al.
Prostate Cancer and Prostatic Diseases|December 12, 2022
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysisTamás Fazekas, Ádám D Széles, Brigitta Teutsch, et al.
Scientific Reports|October 13, 2023
Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective studyMelinda Váradi, Orsolya Horváth, Orsolya Módos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
<sup>68</sup>Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate CancerMaria Vinsensia, Peter L Chyoke, Boris Hadaschik, et al.
BJU International|May 27, 2018
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancerTibor Szarvas, Sabina Sevcenco, Orsolya Módos, et al.
The Journal of Pathology. Clinical Research|January 16, 2025
Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapyCsilla Olah, Oleksandr Shmorhun, Gilbert Georg Klamminger, et al.
Pageof 27